Acasti Pharma (ACST) Q4 2024 Earnings

13NovConfirmed
Q4 2023
Q2 2024
Q3 2024
Q4 2024
-0.37
-0.3
-0.24
-0.17

Details

Expected EPS
-0.37
Actual EPS
-0.3
Surprise EPS
0.07
Surprise Percent
+18.92%

Description

Acasti Pharma (ACST) has reported earnings of -0.3 per share for Q4 2024.

0 Comments

Share your thoughts